Document is current
Any future updates will be listed below
-
Authors
Khateri, Parisa
Koottungal, Tiana
Wong, Damon
Strauss, Rupert W.
Janeschitz-Kriegl, Lucas
Pfau, Maximilian
Schmetterer, Leopold
Scholl, Hendrik P. N.
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_201165, 310030_201165)
National Medical Research Council (OFLCG/004c/2018-00; MOH-000249-00; MOH-000500-00; MOH-000647-00; MOH-000707-00; MOH-001001-00; MOH-001015-00; MOH-001072-06; MOH-001286-00; MOH-001574-02; MOH-001576-00)
National Research Foundation Singapore (NRF2019-THE002-0006; NRF-CRP24-2020-0001)
National Health Innovation Centre Singapore (NHIC-I2D-2402329)
Agency for Science, Technology and Research (A20H4b0141)
SingHealth Foundation (AM/TP085/2024 [SRDUKAMR2485); AM/AIR017/2024 [SRDUKAMR24A7])
Duke-NUS Medical School ((05/FY2022/EX/66-A128; Duke-NUS-KBrFA/2024/0088)
Singapore Eye Research Institute & Nanyang Technological University (SERI-NTU Advanced Ocular Engineering (STANCE) Program)
Singapore Eye Research Institute (I010/2024 [2082/44/2024])
National Center of Competence in Research Molecular Systems Engineering (51NF40-182895)
Wellcome Trust (PINNACLE)
Foundation Fighting Blindness Clinical Research Institute (ProgStar)
- License Information
-
More Information
Article History
Received: 5 October 2024
Accepted: 1 January 2025
First Online: 8 February 2025
Declarations
:
: The authors declare the following competing interests: Dr. Scholl is chief medical officer of Belite Bio and director of Bioptima AG. He is member of the Scientific Advisory Board of: Boehringer Ingelheim Pharma GmbH & Co, Janssen Research & Development, LLC (J&J Innovative Medicine), Kerna Ventures, Okuvision GmbH, and Tenpoint Therapeutics. Dr. Scholl is member of the Investment Advisory Board of Droia NV. Dr. Scholl is a member of the Data Monitoring and Safety Board/Committee of ViGeneron (NCT06291935) and adviser of the Steering Committee of Novo Nordisk (FOCUS trial; NCT03811561). The other authors declare no competing interests.
